Frontlight ResearchEarly access
CompletedNo phase
SYMPHONY-PE Study for Treatment of Pulmonary Embolism
Key facts
- Who runs it
- Imperative Care, Inc.
- Where
- Atlanta, Cincinnati, Dallas, Detroit, Fort Worth, Glenview, Grand Rapids, Greenville, Huntsville, Indianapolis, Jacksonville, Los Angeles, Mount Kisco, New York, Norfolk, Plano, Royal Oak, and Tallahassee, United StatesSee the 19 sites
- Trial code
- Status
- Completed
- People taking part
- 110 people enrolled
- Started
- 13 Dec 2023
- Ended
- 29 May 2025
- Type of study
- Interventional
- Treatments tested
- Symphony Thrombectomy System
- Record updated
- 10 August 2026
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 32 criteriaShow less
Who can take part
- CTA evidence of acute PE within ≤14 days
- Clinical signs and symptoms consistent with acute PE
- Systolic BP ≥90 mmHg with evidence of dilated RV with an RV/LV ratio >0.9 (based on Investigator's assessment of RV/LV ratio)
- Stable heart rate <130 BPM prior to procedure
- Subject is between 18 and 80 years of age
- Subject is willing to sign an IRB-approved informed consent form
- Subject is willing and able to comply with protocol follow-up
Who cannot take part
- Cardiovascular or pulmonary surgery within last 7 days
- Experienced cardiac arrest
- Known bleeding diathesis or coagulation disorder
- Cancer requiring active chemotherapy
- Pulmonary hypertension with peak pulmonary artery pressure >70 mmHg by right heart catheterization
- COVID-19 positive at hospital admission
- International Normalized Ratio (INR) >3
- Platelets <100,000/µL
- Kidney dysfunction as confirmed by serum creatinine >1.8 mg/dL or GFR <45 mL/min
- Hematocrit <28% or hemoglobin <9 g/dL
- History of chronic severe pulmonary hypertension, and/or chronic left heart disease with left ventricular ejection fraction ≤30%
- Thrombolytic use within 14 days of baseline CTA
- Systolic BP <90 mmHg for 15 min or requirement of inotropic support to maintain systolic BP ≥90 mmHg any time after admission
- Has left bundle branch block
- Presence of intracardiac lead in the right ventricle or right atrium
- Presence of intracardiac thrombus
- Major trauma within the past 14 days
- Known serious, uncontrolled sensitivity to radiographic agents
- Contraindication to anticoagulants, i.e., heparin or alternative
- Patient on extracorporeal membrane oxygenation (ECMO)
- Heparin-induced thrombocytopenia (HIT)
- Life expectancy <90 days as determined by investigator
- Pregnant or nursing
- Current participation in another investigational study
- Evidence such as imaging or other that suggests the subject is not appropriate for this procedure (e.g., target vessel size is too small to accommodate 16F or 24F catheters)
Where in United States
- Emory UniversityAtlanta, United States
- Bon Secours Mercy Health, IncCincinnati, United States
- Medical City Dallas HospitalDallas, United States
- Ascension St. John HospitalDetroit, United States
- Medical City Fort Worth HospitalFort Worth, United States
- Endeavor HealthGlenview, United States
- Corewell HealthGrand Rapids, United States
- Prisma HealthGreenville, United States
- Huntsville HospitalHuntsville, United States
- Indiana UniversityIndianapolis, United States
- First Coast Cardiovascular InstituteJacksonville, United States
- Cedars-Sinai Medical CenterLos Angeles, United States
- Northwell HealthMount Kisco, United States
- Icahn School of Medicine at Mount SinaiNew York, United States
- NYU Grossman School of MedicineNew York, United States
- Sentara Norfolk General HospitalNorfolk, United States
- The Heart Hospital Baylor PlanoPlano, United States
- William Beaumont Hospital-Royal OakRoyal Oak, United States
- Tallahassee Memorial HospitalTallahassee, United States
About the trial
What the trial wants to find out
Evaluation of the Safety and Efficacy of the Symphony Thrombectomy System in the Treatment of Pulmonary Embolism
The group in the trial
- Symphony Thrombectomy systemTreatment being tested
Mechanical thrombectomy using the Symphony Thrombectomy system for the treatment of acute pulmonary embolism.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Evaluation of the Safety and Efficacy of the Symphony Thrombectomy System in the Treatment of Pulmonary Embolism
- Publications
- Is There a Golden Hour for Thrombectomy in Intermediate-Risk Pulmonary Embolism? Insights From SYMPHONY-PE.Circulation. Cardiovascular interventions, 2026
- Record updated
- 10 August 2026